Safety and efficacy of ultra-tapered mechanical dilator for EUS-guided hepaticogastrostomy and pancreatic duct drainage compared with electrocautery dilator (with video)

Background and Objectives: Successful tract dilation is one of the most important steps to accomplish EUS-guided drainage. Although mechanical dilation is safer than electrocautery dilation, no dedicated mechanical dilator (MD) is currently available. Thus, we developed a new ultra-tapered MD for EU...

Full description

Saved in:
Bibliographic Details
Published inEndoscopic Ultrasound Vol. 7; no. 6; pp. 376 - 382
Main Authors Honjo, Mitsuyoshi, Itoi, Takao, Tsuchiya, Takayoshi, Tanaka, Reina, Tonozuka, Ryosuke, Mukai, Shuntaro, Sofuni, Atsushi, Nagakawa, Yuichi, Iwasaki, Hidenori, Kanai, Takanori
Format Journal Article
LanguageEnglish
Published China Wolters Kluwer India Pvt. Ltd 01.11.2018
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt Ltd
Subjects
Online AccessGet full text
ISSN2303-9027
2226-7190
DOI10.4103/eus.eus_2_18

Cover

More Information
Summary:Background and Objectives: Successful tract dilation is one of the most important steps to accomplish EUS-guided drainage. Although mechanical dilation is safer than electrocautery dilation, no dedicated mechanical dilator (MD) is currently available. Thus, we developed a new ultra-tapered MD for EUS-guided drainage. This study aimed to evaluate the safety and usefulness of this novel MD. Patients and Methods: Consecutive patients who underwent EUS-guided hepaticogastrostomy (EUS-HGS) or EUS-guided pancreatic duct drainage (EUS-PD) at two centers were included in the study. Dilation of the needle tract was initially performed with a diathermic sheath or the ultra-tapered MD. Technical success and adverse events were assessed. Results: Sixty-four patients (mean age = 68.9 ± 13.8 years, 35 men) underwent EUS-HGS (49 patients) and EUS-PD (15 patients). Thirty-three patients were included in the cautery dilator (CD) group and 31 in the ultra-tapered MD group. Initial dilation of the puncture site was achieved in 95.3% (61/64): 97% (32/33) of the patients in the CD group and 93.3% (29/31) of the patients in the MD group (P < 0.05). Adverse events were observed in 14 patients: abdominal pain in 8 patients and bleeding in 6 patients at the puncture site. All bleedings occurred in the CD group and there was no patient in whom bleeding occurred after EUS intervention in the MD group (P = 0.04). Conclusion: The novel ultra-tapered MD designed for interventional EUS appears to be safe and useful as it reduced postprocedure bleeding with a high technical success rate compared with the conventional electrocautery dilator.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2303-9027
2226-7190
DOI:10.4103/eus.eus_2_18